title: One center's experience with OKT3 in renal transplantation: patient and graft survival, complications, and cost analysis.
authors.affiliation: Department of Nephrology, Başkent University Faculty of Medicine, Ankara, Turkey.
authors.forename: G
authors.initials: G
authors.lastname: Güz
authors.forename: R
authors.initials: R
authors.lastname: Emiroğlu
authors.forename: B
authors.initials: B
authors.lastname: Demirhan
authors.forename: F
authors.initials: F
authors.lastname: Köseoğlu
authors.forename: H
authors.initials: H
authors.lastname: Karakayali
authors.forename: N
authors.initials: N
authors.lastname: Bilgin
mesh_terms: D000328:Adult; D003404:Creatinine / Q000097:blood; D016527:Drug Costs; D004351:Drug Resistance; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D011183:Postoperative Complications; D019233:Retreatment; D013256:Steroids / Q000627:therapeutic use; D016019:Survival Analysis
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D013256:Steroids; D003404:Creatinine